Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

3yrs ago Private Equity privateequitywire Views: 270

Shore Capital's EyeSouth partners with Coastal Eye Associates

Submitted 02/06/2020 - 4:43pm

Shore Capital's portfolio company EyeSouth Partners (EyeSouth) has completed an affiliation with Coastal Eye Associates (CEA). 

The affiliation represents EyeSouth’s first in the state of Texas and sixteenth affiliation overall. EyeSouth is an eye care-focused management services organisation backed by Shore Capital Partners, committed to partnering with leading physicians to build a premier network of eye care services in the South. EyeSouth’s affiliate network consists of 16 practices with approximately 114 doctors providing medical and surgical eye care services at approximately 70 locations including 11 surgery centres throughout Georgia, Texas, Louisiana, North Carolina, Florida, Tennessee and Alabama.

Coastal Eye Associates is led by Drs William McMullen, Gregory Clariday, William Lipsky and Duc Tran and functions with 14 total providers. CEA employs approximately 60 support staff across six primary clinical locations in the Greater Houston area. CEA provides an integrated service model incorporating routine eye exams, advanced therapeutic treatment and surgical solutions supported by a retail presence at each clinical location.

McMullen says: “Since our founding over 20 years ago, we have aspired to provide high-quality patient care and continued growth to support the Greater Houston community. While EyeSouth is committed to providing experienced operational support and resources to our practice, it was critical that our physicians maintain control of medical decisions related to patient care.”

“We are very excited to expand into the state of Texas with a leading and highly-respected ophthalmology practice in Coastal Eye Associates,” says Dr Eugene Gabianelli, MD, Chief Medical Officer of EyeSouth Partners. “We see significant opportunity to exchange best practices and further enhance and execute on the practice’s operational and growth strategy.”

Tags Deals & Transactions

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.